Model for end-stage liver disease (MELD) for liver allocation: A 5-year score card
- 1 March 2008
- journal article
- review article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 47 (3) , 1052-1057
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Survival Benefit: Quality Versus Quantity and Trade-offs in Developing New Renal Allocation SystemsAmerican Journal of Transplantation, 2007
- Model for end-stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formulaLiver Transplantation, 2006
- Utility Is Not Just Posttransplant Outcome!American Journal of Transplantation, 2006
- A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantationLiver Transplantation, 2005
- The Survival Benefit of Liver TransplantationAmerican Journal of Transplantation, 2004
- Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: A decision analysisLiver Transplantation, 2004
- Results of the first year of the new liver allocation planLiver Transplantation, 2004
- Liver transplantation for hepatocellular carcinoma: Analysis of survival according to the intention-to-treat principle and dropout from the waiting listLiver Transplantation, 2002
- STUDIES OF PEDIATRIC LIVER TRANSPLANTATION (SPLIT): YEAR 2000 OUTCOMESTransplantation, 2001
- Liver transplant waiting time does not correlate with waiting list mortality: Implications for liver allocation policyLiver Transplantation, 2000